← Browse by Condition
Medical Condition

breast cancer

Total Trials
152
Recruiting Now
152
Trial Phases
Phase 2, Phase 1, Phase 3
NCT05573893
Recruiting

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

Enrollment
800 pts
Location
Germany
Sponsor
AstraZeneca
View Trial →
NCT04965064 Phase 2
Recruiting

Trial of Neratinib Plus Capecitabine in Subjects With HER2-Negative Metastatic Breast Cancer With Brain Metastases and Abnormally Active HER2 Signaling

Enrollment
22 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT03449264
Recruiting

Development of Clinical and Biological Database

Enrollment
4,000 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
View Trial →
NCT06272864
Recruiting

BostonGene and Exigent Genomic INsight Study

Enrollment
400 pts
Location
United States
Sponsor
BostonGene
View Trial →
NCT05787587 Phase 1
Recruiting

A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors

Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
View Trial →
NCT02535221 Phase 3
Recruiting

Neoadjuvant Endocrine Therapy Versus Chemotherapy in Premenopausal Patients With ER+ & HER2- Breast Cancer

Enrollment
234 pts
Location
China
Sponsor
Peking University
View Trial →
NCT05468034
Recruiting

Exercise in Metastatic Breast Cancer: EMBody

Enrollment
100 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06609187 Phase 1
Recruiting

A Study of GNC-077 in Patients With Locally Advanced or Metastatic Breast Cancer and Other Solid Tumors

Enrollment
20 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
View Trial →
NCT06215469
Recruiting

Portable Scalp Cooling System (PSCS) to Prevent Hair Loss for Breast Cancer Patients (Cooler Heads)

Enrollment
40 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT06115902 Phase 1
Recruiting

A Study of TQB2102 for Injection in Patients With Recurrent/Metastatic Breast Cancer

Enrollment
150 pts
Location
China
Sponsor
Chia Tai Tianqing Pharmaceutic...
View Trial →
NCT07117630 Phase 2
Recruiting

An Open-Label, Bayesian Adaptive Phase II Clinical Study in HR+/HER2- Advanced Breast Cancer After Progression on Standard Therapy

Enrollment
20 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT06977360
Recruiting

Feasibility, Acceptability and Preliminary Efficacy of the New Iteration of the Innovative Smartphone-based Care Solution for Women With Breast Cancer Undergoing Chemotherapy (iCareBreast+): A Pilot Study Research Proposal

Enrollment
40 pts
Location
Singapore
Sponsor
National Cancer Centre, Singap...
View Trial →
NCT06533059 Phase 1
Recruiting

A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors

Enrollment
110 pts
Location
United States, Austr...
Sponsor
Alterome Therapeutics, Inc.
View Trial →
NCT04608357
Recruiting

Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients

Enrollment
25 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT06694181
Recruiting

Safe and Explainable AI

Enrollment
300,000 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn...
View Trial →
NCT05305092
Recruiting

Assessment of Brain Cognitive Impairment in Breast Cancer

Enrollment
90 pts
Location
China
Sponsor
Tang-Du Hospital
View Trial →
NCT04019678
Recruiting

Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.

Enrollment
850 pts
Location
Italy
Sponsor
Istituto Clinico Humanitas
View Trial →
NCT07260591 Phase 1
Recruiting

VSV-02 Compassionate Use in Advanced Solid Tumors

Enrollment
6 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT05412225 Phase 1
Recruiting

A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast Cancer

Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06900374
Recruiting

Efficacy and Safety of Vaginal Radiofrequency for Vulvovaginal Atrophy in Breast Cancer Patients

Enrollment
75 pts
Location
France
Sponsor
Centre Oscar Lambret
View Trial →
NCT06010862 Phase 1
Recruiting

Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors

Enrollment
36 pts
Location
China
Sponsor
Chongqing Precision Biotech Co...
View Trial →
NCT06738459
Recruiting

Precision Retrospective Integrative Study for Metastatic Lymph Nodes in Breast Cancer

Enrollment
1,500 pts
Location
Austria, Italy
Sponsor
Centro di Riferimento Oncologi...
View Trial →
NCT02926729
Recruiting

Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy

Enrollment
98 pts
Location
United States
Sponsor
Beth Israel Deaconess Medical ...
View Trial →
NCT05349227
Recruiting

Comprehensive Outcomes for After Cancer Health

Enrollment
625 pts
Location
United States
Sponsor
Pack Health
View Trial →
NCT06452394 Phase 2
Recruiting

NEODOXy: Targeting Breast Cancer Stem Cells With Doxycycline

Enrollment
50 pts
Location
Switzerland
Sponsor
Swiss Cancer Institute
View Trial →
NCT05228951 Phase 2
Recruiting

Pyrotinib Maleate, Trastuzumab, SHR6390 and Letrozole in Combination for Stage II-III TPBC

Enrollment
12 pts
Location
China
Sponsor
Shengjing Hospital
View Trial →
NCT04342546
Recruiting

Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction

Enrollment
250 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
View Trial →
NCT03580109
Recruiting

Spa Therapy for Upper or Lower Limb Lymphoedema

Enrollment
160 pts
Location
France
Sponsor
Association Francaise pour la ...
View Trial →
NCT03796559
Recruiting

Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

Enrollment
65 pts
Location
United States
Sponsor
Endomagnetics Ltd.
View Trial →
NCT06107673 Phase 2
Recruiting

Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer (EBC)

Enrollment
144 pts
Location
China
Sponsor
Hebei Medical University Fourt...
View Trial →
NCT05867966
Recruiting

Psychoneurological Symptom Cluster in Oncology

Enrollment
500 pts
Location
Belgium
Sponsor
University of Liege
View Trial →
NCT04925856
Recruiting

Immunomonitoring of Breast Cancer Patients During Systemic Treatment

Enrollment
150 pts
Location
France
Sponsor
Centre Georges Francois Lecler...
View Trial →
NCT05907681
Recruiting

Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

Enrollment
400 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT06830083
Recruiting

Hypofractionated Radiation Fractionation in Breast Cancer Patients with Implant-Based Reconstruction

Enrollment
840 pts
Location
China
Sponsor
The First Affiliated Hospital ...
View Trial →
NCT05658341
Recruiting

Program of Physical Activity, Nutrition and Supportive to Improve the Quality of Life of Breast Cancer Survivors

Enrollment
160 pts
Location
France
Sponsor
Siel Bleu
View Trial →
NCT07055854 Phase 1
Recruiting

Virtual Mindful After Cancer (MAC) Intervention to Promote Sexual Health for Breast and Gynecologic Cancer Survivors

Enrollment
60 pts
Location
United States
Sponsor
Oregon State University
View Trial →
NCT06840483 Phase 2
Recruiting

Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer

Enrollment
66 pts
Location
United States, Austr...
Sponsor
BicycleTx Limited
View Trial →
NCT05350527
Recruiting

Impact of Video Information Support on Preoperative Anxiety in Breast Cancer Surgery

Enrollment
200 pts
Location
France
Sponsor
University Hospital, Montpelli...
View Trial →
NCT07135661
Recruiting

Ultra-Hypofractionated vs. Moderately Hypofractionated Proton Therapy for Early Breast Cancer After Lumpectomy

Enrollment
312 pts
Location
China
Sponsor
Shanghai Proton and Heavy Ion ...
View Trial →
NCT01521676
Recruiting

Predictive Clinical and Biological Parameters in Breast Cancer

Enrollment
750 pts
Location
France
Sponsor
Institut Paoli-Calmettes
View Trial →
NCT06042894 Phase 2
Recruiting

A Study of SI-B003 or BL-B01D1+SI-B003 in Patients With Unresectable Locally Advanced or Recurrent Metastatic HER2 Negative Breast Cancer

Enrollment
58 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
View Trial →
NCT06395519 Phase 1, Phase 2
Recruiting

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Enrollment
120 pts
Location
United States
Sponsor
858 Therapeutics, Inc.
View Trial →
NCT06093022
Recruiting

Surgical or Medical Treatment of Breast Cancer Metastasis: A Multicentre Observational Study

Enrollment
720 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
View Trial →
NCT06413212
Recruiting

Exploratory Study of Precise Therapy for Advanced Tumor Patients With Malignant Hydrothorax or Ascites by Using PTC Drug Sensitivity Testing

Enrollment
55 pts
Location
China
Sponsor
Liu Huang
View Trial →
NCT06568692 Phase 2
Recruiting

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

Enrollment
90 pts
Location
United States
Sponsor
Processa Pharmaceuticals
View Trial →
NCT07416630
Recruiting

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

Enrollment
30 pts
Location
Slovenia
Sponsor
Institute of Oncology Ljubljan...
View Trial →
NCT07216105 Phase 1
Recruiting

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

Enrollment
113 pts
Location
United States
Sponsor
Fate Therapeutics
View Trial →
NCT05835739
Recruiting

InheriteD brEast caNcer iTalian regIsTrY A Retrospective-prospective Observational Cohort Study to Evaluate Cancer Prevention Strategies in Women With a Deleterious Mutation in BRCA1-2

Enrollment
78 pts
Location
Italy
Sponsor
Centro di Riferimento Oncologi...
View Trial →
NCT06905561
Recruiting

Topical Diclofenac for Prevention of Radiation-induced Dermatitis

Enrollment
156 pts
Location
China
Sponsor
The Second Affiliated Hospital...
View Trial →
NCT06727227
Recruiting

Real-world Study of Trastuzumab Deruxtecan in Patients With Unresectable or Metastatic HER2-low Breast Cancer

Enrollment
135 pts
Location
Bulgaria, Slovenia
Sponsor
AstraZeneca
View Trial →
NCT04472845
Recruiting

HYPofractionated Adjuvant RadioTherapy in 1 Versus 2 Weeks in High-risk Patients With Breast Cancer (HYPART).

Enrollment
1,018 pts
Location
India
Sponsor
Post Graduate Institute of Med...
View Trial →
NCT04383275 Phase 2
Recruiting

Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS)

Enrollment
356 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT07396766
Recruiting

Dissemination of BREASTChoice AIM1-B

Enrollment
20 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
View Trial →
NCT05509751
Recruiting

The SOAR Study: a Study of Geriatric Assessment and Exercise for Older Adults and Their Support Person

Enrollment
60 pts
Location
Canada
Sponsor
Martine Puts
View Trial →
NCT05732051 Phase 2
Recruiting

Nicotinamide Riboside and Prevention of Cancer Therapy Related Cardiac Dysfunction in Breast Cancer Patients

Enrollment
60 pts
Location
Norway
Sponsor
University Hospital, Akershus
View Trial →
NCT05458674 Phase 2
Recruiting

Tucatinib+Trastuzumab+Eribulin in HER2+ MBC

Enrollment
30 pts
Location
United States
Sponsor
Criterium, Inc.
View Trial →
NCT06864754
Recruiting

WashU DIEP Flap Video and Patient Understanding Improvement

Enrollment
300 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT06053086
Recruiting

SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technology

Enrollment
500 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
View Trial →
NCT07057427 Phase 3
Recruiting

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

Enrollment
812 pts
Location
China
Sponsor
Henan Cancer Hospital
View Trial →
NCT04050423
Recruiting

Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses

Enrollment
1,200 pts
Location
Canada
Sponsor
Sunnybrook Health Sciences Cen...
View Trial →
NCT06103669
Recruiting

Locally AblatiVe TherApy in OLigO-pRogressive SOlid TUmorS (VALOROUS)

Enrollment
250 pts
Location
United States
Sponsor
University of California, Davi...
View Trial →
NCT04468061 Phase 2
Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Enrollment
110 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT06819215 Phase 1, Phase 2
Recruiting

Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors

Enrollment
188 pts
Location
China
Sponsor
Zhejiang Yangli Pharmaceutical...
View Trial →
NCT07231159
Recruiting

Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

Enrollment
200 pts
Location
United States
Sponsor
AdventHealth
View Trial →
NCT06415162
Recruiting

Evaluation of the Effects of Using Cooling Pillowcases, on the Symptoms of Hot Flushes, Sleep and Life Quality

Enrollment
64 pts
Location
Turkey (Türkiye)
Sponsor
Saglik Bilimleri Universitesi
View Trial →
NCT06649565
Recruiting

Prospective Validation and Application of an Artificial Intelligence-based Model for Evaluating the Efficacy of Breast Cancer Patients After Neoadjuvant Therapy

Enrollment
300 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →
NCT05856773 Phase 3
Recruiting

Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

Enrollment
276 pts
Location
United States
Sponsor
Proton Collaborative Group
View Trial →
NCT06313983 Phase 3
Recruiting

A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer

Enrollment
339 pts
Location
China
Sponsor
Tianjin Hemay Pharmaceutical C...
View Trial →
NCT06155305
Recruiting

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer

Enrollment
58 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT06440005 Phase 1
Recruiting

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

Enrollment
80 pts
Location
United States
Sponsor
Angiex, Inc.
View Trial →
NCT07205822 Phase 3
Recruiting

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

Enrollment
100 pts
Location
United States, China...
Sponsor
AstraZeneca
View Trial →
NCT07220967 Phase 4
Recruiting

A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement

Enrollment
392 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06508307 Phase 1
Recruiting

A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors

Enrollment
21 pts
Location
China
Sponsor
GONGCHU Biotechnology Co., Ltd
View Trial →
NCT05578053
Recruiting

Efficacy and Safety of Dalpiciclib in Hormone Receptor-positive Advanced Breast Cancer

Enrollment
420 pts
Location
China
Sponsor
Hebei Medical University Fourt...
View Trial →
NCT03954431
Recruiting

High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)

Enrollment
600 pts
Location
United States
Sponsor
University of Arizona
View Trial →
NCT03804944 Phase 2
Recruiting

Converting HR+ Breast Cancer Into an Individualized Vaccine

Enrollment
100 pts
Location
United States
Sponsor
Weill Medical College of Corne...
View Trial →
NCT07478016
Recruiting

EXploring Inflammation and Social deTerminants Study in Breast Cancer Patients

Enrollment
200 pts
Location
United States
Sponsor
Thomas Jefferson University
View Trial →
NCT02743858
Recruiting

Lymphedema Surveillance Study

Enrollment
1,250 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT07179744
Recruiting

Regional Radiotherapy Omission in Low-Risk Node Positive Breast Cancer

Enrollment
635 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...
View Trial →
NCT05300464
Recruiting

A Clinical Investigation to Confirm the Ability of MammoWave in Breast Lesions Detection

Enrollment
600 pts
Location
Italy, Spain
Sponsor
Umbria Bioengineering Technolo...
View Trial →
NCT05972343
Recruiting

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

Enrollment
100 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT06645808 EARLY_Phase 1
Recruiting

PET-imaging of Two Vartumabs in Patients With Solid Tumors

Enrollment
32 pts
Location
Netherlands
Sponsor
Var2 Pharmaceuticals
View Trial →
NCT03870620
Recruiting

Metastatic Breast Cancer in Austria

Enrollment
5,000 pts
Location
Austria
Sponsor
Arbeitsgemeinschaft medikament...
View Trial →
NCT01766297 Phase 2
Recruiting

Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer

Enrollment
132 pts
Location
United States
Sponsor
Proton Collaborative Group
View Trial →
NCT06522568
Recruiting

Testing a Mammography Decision Intervention in a Rural Setting

Enrollment
39 pts
Location
United States
Sponsor
Dartmouth-Hitchcock Medical Ce...
View Trial →
NCT04711824 Phase 1, Phase 2
Recruiting

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

Enrollment
41 pts
Location
United States
Sponsor
Colette Shen
View Trial →
NCT05062707
Recruiting

Early Ageing During Therapy in AYA Cancer Patients

Enrollment
120 pts
Location
Netherlands
Sponsor
University Medical Center Gron...
View Trial →
NCT05032768
Recruiting

The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients

Enrollment
100 pts
Location
China
Sponsor
Fudan University
View Trial →
NCT05921279
Recruiting

Understanding CARdiac Events in Breast Cancer

Enrollment
100 pts
Location
Ireland
Sponsor
National University of Ireland...
View Trial →
NCT05394259 Phase 1
Recruiting

A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer

Enrollment
36 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
NCT02476786 Phase 2
Recruiting

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

Enrollment
50 pts
Location
United States
Sponsor
Washington University School o...
View Trial →
NCT05056350
Recruiting

Professional Life After Breast Cancer: Feasibility of a Coaching Program for an Adapted Return to Work

Enrollment
25 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
View Trial →
NCT05556473 Phase 1
Recruiting

F-Tryptophan PET/CT in Human Cancers

Enrollment
24 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...
View Trial →
NCT04418856
Recruiting

The Effects of Light Therapy to Treat Cancer-related Side Effects

Enrollment
240 pts
Location
Iceland
Sponsor
Reykjavik University
View Trial →
NCT03787056
Recruiting

Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients

Enrollment
410 pts
Location
France
Sponsor
Hospices Civils de Lyon
View Trial →
NCT06580002 Phase 2
Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Enrollment
51 pts
Location
United States
Sponsor
University of California, Irvi...
View Trial →
NCT06610539
Recruiting

PAS 1ml Magtrace® for Sentinel Lymph Node Biopsy in Breast Cancer Patients

Enrollment
184 pts
Location
United States
Sponsor
Endomagnetics Ltd.
View Trial →
NCT06760507
Recruiting

Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics

Enrollment
3,209 pts
Location
United States
Sponsor
Emory University
View Trial →
NCT06067503 Phase 2
Recruiting

Biomarkers to Detect Endocrine Therapy Resistance

Enrollment
8 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →
NCT04282122
Recruiting

Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity

Enrollment
500 pts
Location
France
Sponsor
Institut du Cancer de Montpell...
View Trial →
NCT02302742
Recruiting

Triple Negative Breast Cancer and Germline Hereditary Breast and Ovarian Cancer Mutation Carrier Registry

Enrollment
1,500 pts
Location
United States
Sponsor
University of Kansas Medical C...
View Trial →
NCT07483307 Phase 2
Recruiting

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Breast Cancer

Enrollment
176 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06251401
Recruiting

Cardiac Rehabilitation for Breast Cancer Survivors

Enrollment
50 pts
Location
Canada
Sponsor
Women's College Hospital
View Trial →
NCT04886531 Phase 2
Recruiting

Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Positive, HER-2 Positive Breast Cancers

Enrollment
30 pts
Location
United States
Sponsor
Ruth O'Regan
View Trial →
NCT06602167
Recruiting

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Enrollment
220 pts
Location
China
Sponsor
Affiliated Hospital of Qinghai...
View Trial →
NCT05763992 Phase 2
Recruiting

Targeting Triple Negative BREAst Cancer Metabolism With a Combination of Chemoimmunotherapy and a FASTing-like Approach in the Preoperative Setting: the BREAKFAST 2 Trial

Enrollment
145 pts
Location
Italy
Sponsor
Fondazione IRCCS Istituto Nazi...
View Trial →
NCT04960839
Recruiting

Prophylactic Irradiation to the Contralateral Breast for BCAs Patients

Enrollment
323 pts
Location
China, Singapore
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT05414357
Recruiting

Impact of Sleep Disturbance on Cognition and Quality of Life in Breast Cancer

Enrollment
75 pts
Location
France
Sponsor
Centre Francois Baclesse
View Trial →
NCT06411457 Phase 2
Recruiting

SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer

Enrollment
20 pts
Location
China
Sponsor
Cancer Institute and Hospital,...
View Trial →
NCT05472792 Phase 2
Recruiting

Compare Adjuvant Monotherapy With Endocrine or Accelerated Partial Breast Irradiation After Lumpectomy

Enrollment
90 pts
Location
United States
Sponsor
UNC Lineberger Comprehensive C...
View Trial →
NCT05145244
Recruiting

Copenhagen Master Observational Trial

Enrollment
2,400 pts
Location
Denmark
Sponsor
Rigshospitalet, Denmark
View Trial →
NCT05063136 Phase 3
Recruiting

Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer

Enrollment
1,979 pts
Location
China
Sponsor
Henan Cancer Hospital
View Trial →
NCT07160439
Recruiting

Evaluating Digital Micro-Interventions to Reduce Distress and Increase Wellbeing in Breast Cancer Survivors

Enrollment
120 pts
Location
United States
Sponsor
University of Virginia
View Trial →
NCT06387901
Recruiting

Investigating Paclitaxel Toxicity in Breast Cancer: the Roles of Physical Activity and Body Composition.

Enrollment
40 pts
Location
Belgium
Sponsor
Universitair Ziekenhuis Brusse...
View Trial →
NCT05420454 Phase 4
Recruiting

A Study for the Neoadjuvant Treatment of Breast Cancer

Enrollment
1,576 pts
Location
China
Sponsor
Second Affiliated Hospital, Sc...
View Trial →
NCT05893966
Recruiting

Prospective Cohort for Tumor Bed Boost Radiotherapy in HER2 Positive Breast Cancer

Enrollment
400 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT07238894
Recruiting

A Cohort Study of Combined Cryoablation and Thermal Ablation for Non-surgical Treatment of Breast Cancer Patients

Enrollment
200 pts
Location
China
Sponsor
Peking University People's Hos...
View Trial →
NCT06106529 Phase 3
Recruiting

REDucing Hot FLASHes in Women Using Endocrine Therapy.

Enrollment
260 pts
Location
Netherlands
Sponsor
Reinier de Graaf Groep
View Trial →
NCT06517212 Phase 2
Recruiting

Tirzepatide Weight Loss for MRD+ Early Breast Cancer

Enrollment
48 pts
Location
United States
Sponsor
Baylor Research Institute
View Trial →
NCT05306600
Recruiting

Onco-Genomas Brasil: Mapping Breast and Prostate Cancer in the Brazilian Public Health System

Enrollment
882 pts
Location
Brazil
Sponsor
Hospital Moinhos de Vento
View Trial →
NCT05797545
Recruiting

Comparison of Ultrasound and Breast MRI for Breast Cancer Detection

Enrollment
1,756 pts
Location
South Korea
Sponsor
Samsung Medical Center
View Trial →
NCT06938581
Recruiting

ERAS Protocols in Breast Conserving Surgery

Enrollment
260 pts
Location
United States
Sponsor
University of Nebraska
View Trial →
NCT04084730 Phase 2
Recruiting

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

Enrollment
280 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance...
View Trial →
NCT06334445
Recruiting

CARDIOCARE Prospective Clinical Study

Enrollment
736 pts
Location
Italy
Sponsor
European Institute of Oncology
View Trial →
NCT06048835
Recruiting

Circulating Tumour Cells Characterization in Breast Cancer Patients

Enrollment
80 pts
Location
Italy
Sponsor
Istituti Clinici Scientifici M...
View Trial →
NCT06927648
Recruiting

CAPIVASERTIB REGULATORY POSTMARKETING SURVEILLANCE IN KOREA

Enrollment
130 pts
Location
South Korea
Sponsor
AstraZeneca
View Trial →
NCT07003074 Phase 3
Recruiting

A Clinical Study of TQB2102 Versus Docetaxel Plus Trastuzumab and Pertuzumab in the Treatment of HER2 Positive Recurrent or Metastatic Breast Cancer

Enrollment
642 pts
Location
China
Sponsor
Chia Tai Tianqing Pharmaceutic...
View Trial →
NCT07108517
Recruiting

A Manualized Post-Traumatic Growth Intervention for People With Cancer in Greece - IC-Growth

Enrollment
180 pts
Location
Greece
Sponsor
Centre for Research and Techno...
View Trial →
NCT07131735
Recruiting

Intraoperative Detection of Breast Cancer by Electrosurgical Gas Analysis and Artificial Intelligence

Enrollment
30 pts
Location
Chile
Sponsor
Pontificia Universidad Catolic...
View Trial →
NCT04585750 Phase 1, Phase 2
Recruiting

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Enrollment
300 pts
Location
United States, Austr...
Sponsor
PMV Pharmaceuticals, Inc
View Trial →
NCT05692674 Phase 2
Recruiting

A Prospective Phase II Study for Adjuvant Hypofractionated Intensity-modulated Proton Radiotherapy for Post Operative Breast Cancer With Implantation Reconstruction

Enrollment
67 pts
Location
China
Sponsor
Shanghai Proton and Heavy Ion ...
View Trial →
NCT06726889
Recruiting

Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients

Enrollment
104 pts
Location
Italy
Sponsor
European Institute of Oncology
View Trial →
NCT06282796
Recruiting

Early Prediction and Warning for Cardiotoxicity Due to Anthracycline-Based Breast Cancer Chemotherapy

Enrollment
600 pts
Location
China
Sponsor
First Hospital of China Medica...
View Trial →
NCT06503783 Phase 1
Recruiting

A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors

Enrollment
20 pts
Location
China
Sponsor
Sichuan Baili Pharmaceutical C...
View Trial →
NCT05184582
Recruiting

Physical Exercise During Preoperative Chemotherapy for Breast Cancer

Enrollment
712 pts
Location
Australia, Finland, ...
Sponsor
Karolinska Institutet
View Trial →
NCT04680442 Phase 2
Recruiting

Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

Enrollment
130 pts
Location
Brazil, Canada, Russ...
Sponsor
Population Health Research Ins...
View Trial →
NCT06322888
Recruiting

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Enrollment
46 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
View Trial →
NCT04119024 Phase 1
Recruiting

Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors

Enrollment
18 pts
Location
United States
Sponsor
Anusha Kalbasi
View Trial →
NCT06086704 Phase 2
Recruiting

Study of 18F-FFNP Breast PET/MRI

Enrollment
53 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →
NCT06523452
Recruiting

Laser Speckle Imaging During Breast Reconstruction

Enrollment
60 pts
Location
United Kingdom
Sponsor
Royal Devon and Exeter NHS Fou...
View Trial →
NCT06773533
Recruiting

Registry of Adjuvant Hormone-blockade Breast Cancer Patients Evaluated for Bone Mineral Metabolism

Enrollment
3,000 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
View Trial →
NCT05452213 Phase 4
Recruiting

Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients

Enrollment
1,000 pts
Location
Germany
Sponsor
Institut fuer Frauengesundheit
View Trial →
NCT03635723
Recruiting

Breast: Recovery After Axillary Node Clearance - Evaluating Limbs With E-Technology (the BRACELET Study)

Enrollment
75 pts
Location
United Kingdom
Sponsor
Imperial College London
View Trial →
NCT03936478 Phase 2
Recruiting

Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer

Enrollment
30 pts
Location
United States
Sponsor
University of Wisconsin, Madis...
View Trial →
NCT04916990
Recruiting

Improving Care for Rural Patients With Solid Tumors

Enrollment
320 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05728268 Phase 2
Recruiting

Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index

Enrollment
64 pts
Location
China
Sponsor
Shantou Central Hospital
View Trial →
NCT07042243
Recruiting

The Florida ASCENT Study

Enrollment
100 pts
Location
United States
Sponsor
University of Florida
View Trial →
NCT05044689
Recruiting

Case Control Study to Identify Modifiable Risk Factors for Colorectal and Breast Cancer in Nigeria

Enrollment
800 pts
Location
Nigeria
Sponsor
Obafemi Awolowo University Tea...
View Trial →
NCT06957535
Recruiting

Community-led Navigation to Address Disparities in Mammography Among Native American Women

Enrollment
200 pts
Location
United States
Sponsor
Johns Hopkins Bloomberg School...
View Trial →
NCT06425874
Recruiting

The Impact of Socioeconomic Determinants on the Patient Reported Outcomes in Young Breast Cancer Patients After Breast Surgery

Enrollment
1,000 pts
Location
China
Sponsor
Sun Yat-Sen Memorial Hospital ...
View Trial →
NCT06307249 Phase 1
Recruiting

Precision Therapy for Solid Tumors: Synergistic CDK4/6 Inhibition and Anti-VEGF Targeting LncRNA

Enrollment
50 pts
Location
Lebanon
Sponsor
Lebanese University
View Trial →
NCT05592938
Recruiting

Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)

Enrollment
171 pts
Location
United States, Austr...
Sponsor
University Health Network, Tor...
View Trial →